Corporate News Details
Mankind Pharma receives ratings action from ICRA
(17-Jan-26 12:17)
Mankind Pharma announced that ICRA has assigned the rating ICRA AA+; Stable / ICRA A1+ for debt facilities of the company including non-convertible debentures. The rating on commercial paper of ICRA A1+ has been withdrawn.
Powered by Capital Market - Live News
